logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

mCRPC: dual blockade fails to boost PFS after enzalutamide in PLATO

Abiraterone failed to reinduct sensitivity to androgen receptor antagonism.